While some investors choose to go it alone and select individual stocks for the income portion of their portfolio, the beauty of high yield ETFs is that they spread
the individual company risk across several issues, often across sectors, and sometimes, even across countries.
Not exact matches
If even a single EU citizen visits the website of a
company based anywhere in the world and data is collected on that
individual, that
company must comply with GDPR or
risk severe penalization.
That research will be crucial: An earlier effort by another
company, Pathway Genomics, to create a «liquid biopsy» for cancer was greeted in September by a stern letter from the Food and Drug Administration (FDA) warning that the agency had «not found any published evidence that this test or any similar test has been clinically validated as a screening tool for early detection of cancer in high
risk individuals.»
«Social media may be a huge opportunity for your employees to help build your
company's brand, but let's not forget that there also exists a tremendous
risk for
individual employees to inadvertently damage the
company's brand and by defining a set of guidelines you help mitigate that
risk.»
Companies and even
individuals who are slandered on the internet have little or no recourse unless it's through identity theft insurance or reputational
risk insurance.
Consumers are turning to ever - cheaper, spit - and - send genetic test kits offered by
companies like Color Genomics and 23andMe, to forewarn them of specific genetic susceptibilities — an awareness that, boosters say, can sometimes enable
individuals to take preventive action that may mitigate those
risks.
One
risk for news
companies and publishers is that as more of their content is found via social networks such as Facebook or aggregators like Apple News (aapl), the power of their
individual brands tends to decrease.
They also allow those investors to avoid the high costs of stock - brokerage commissions and financial planning fees that eat into returns, as well as the
risks of investing in
individual companies that may choose less - competent leaders or run into unforeseen problems.
We're certainly willing to take on certain
risks specific
individual companies, so we remain fully invested in a well diversified portfolio of stocks.
Total Compensation: In aggregate, the key elements of compensation below provide for an emphasis on performance and at -
risk pay, with a significant upside based on exceptional
Company and
individual performance.
Risk associated with equity investing include stock values which may fluctuate in response to the activities of
individual companies and general market and economic conditions.
As an underwriting
company, Chubb assesses, assumes and manages
risk with insight and discipline, and combines the precision of craftsmanship with decades of experience to conceive, craft and deliver the best insurance coverage and services to
individuals, families and business of all size.
description of the
Company's compensation program governance, including the independence of each member of the HRC,
Company performance, peer group analysis, business line performance,
individual performance, independent compensation consultant advice,
risk management, and HRC discretion; and
The 401 (k) plan on balance weakened Federal incentives for profit sharing and encouraged employees to buy stock in their
companies with their wages, which gave them greater
individual risk exposure than when they received grants of stock.17
In healthcare, Pfizer and other pharmaceutical
companies have lined up one - off funding for the development of specific products, matching their capital needs with the
risk preferences and expertise of
individual investors.
Chinese
companies have also learned to look into each
individual country separately to avoid misjudge the political, labour and environmental
risk that foreign business environments present distinctively.
The
company provides a marketplace for buyers and sellers, bringing together
individuals,
companies and institutions that need to manage
risk or that want to profit by accepting
risk.
It's nonsensical and undemocratic: All
individuals should have the right to accept
risk and invest in the
companies they believe in.
It is very common amongst
companies and
individuals who do business in high
risk areas (where kidnapping is common), such as the Middle East.
Default
Risk is when
companies or
individuals will be unable to make the required payments on their debt obligations.
This lowers your
risk around any
individual company and helps you earn the market return.
When launched our global asset management
company for affluent and high net worth
individuals, families and institutions that wanted to invest alongside us, we made sure our initial Form ADV disclosures contained discussions about some of the
risks.
RepRisk, a business service that advises stakeholders on the environmental and social
risks associated with
individual companies, lists on is website «The Most Controversial Mining Companies of 201
companies, lists on is website «The Most Controversial Mining
Companies of 201
Companies of 2011.»
Of course,
individual companies have headaches hedging against their specific currency
risks.
On the other hand, stocks (and equity - related mutual funds) involve an assortment of
risks ranging from
individual company performance to industry - specific factors to the fitness of the general economy.
Fund
companies employ teams of portfolio managers, analysts, fund accountants, compliance and
risk monitoring personnel, and many other
individuals who are in charge of managing the investment strategies that are offered by the fund
company.
IF THE
COMPANY BELIEVES, IN ITS SOLE DISCRETION, THAT ANY
INDIVIDUALS OR ENTITIES OWNING CTK CREATES MATERIAL REGULATORY OR OTHER LEGAL
RISKS OR ADVERSE EFFECTS FOR THE
COMPANY AND / OR CTK, THE
COMPANY RESERVES THE RIGHT TO: (A) BUY ALL CTK FROM SUCH CTK OWNERS AT THE THEN - EXISTING MARKET PRICE AND / OR (B) SELL ALL CRYPTOCURRENCY ASSETS OF THE
COMPANY.
George Budwell (iShares Nasdaq Biotechnology Index): Although the biotech industry is growing by leaps and bounds at the moment, the fact remains that
individual companies — and even titans of the industry like Gilead Sciences — are fraught with clinical, regulatory, and commercial
risk.
But it has been disappointing in that the kind of genetic variation it detects has turned out to explain surprisingly little of the genetic links to most diseases... One issue of debate among researchers is whether, despite the prospect of diminishing returns, to continue with the genomewide studies, which cost many millions of dollars apiece, or switch to a new approach like decoding the entire genomes of
individual patients.The unexpected impasse also affects
companies that offer personal genomic information and that had assumed they could inform customers of their genetic
risk for common diseases, based on researchers» discoveries...
If the
company fails to comply then when any of those
individuals come to Europe they will be
risking arrest for contempt of court.
However, security software
company Symantec says
individual voters are not at any real
risk, and it has not seen a single incident of external attackers interfering with voters.
So, if a pharmaceutical
company creates an Alzheimer's drug to target memory based on research into one type of memory — the part of the brain responsible for finding missing objects, for example — but doesn't also have data on the type of memory that helps
individuals remember the important people, places and things in their life, it runs the
risk of producing a product that helps a person remember where they put the car keys, but not how they met their spouse.
The case highlights concerns that a network of
individual gene patents could threaten the future of personalized medicine and whole - genome sequencing by blocking
companies and clinicians from reporting a patient's genetic
risk factors for different diseases.
deCODE has identified key variations in the sequence of the genome conferring increased
risk of major public health challenges from cardiovascular disease to cancer, and employs its gene discovery engine to develop DNA - based tests to assess
individual risk of common diseases; to license its tests and intellectual property to partners; and to provide comprehensive, leading - edge contract services to
companies and research institutions around the globe.
This isn't to say the beginnings of personalized medicine haven't arrived — some biotechnology
companies already offer
individual DNA reports that provide people with information about disease
risks and possible drug interactions based on a DNA sample [source: Pathway Genomics].
The same staff and facility also process deCODE's DNA - based reference laboratory tests for gauging
individual risk of major public health challenges ranging from heart attack to breast cancer, as well as the
company's pioneering deCODEme ™ scans, the world's first personal genome analysis and focused disease area scans.
deCODE will employ its CLIA - registered genotyping laboratory and existing testing platform to swiftly integrate the finding into its deCODEme ™ personal genome scan, and to assess the addition of this new variant to the
company's deCODE T2 ™ reference laboratory test for assesing
individual risk of type 2 diabetes.
The
company that has led in the discovery of genes that confer
risk of common diseases is empowering
individuals to explore their own genome Reykjavik, ICELAND, Nov. 16, 2007 — deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODEme ™, a pioneering service...
The effective method to help avoid
risking the
company or
individual and choosing the right conduct path.
This isn't meant as a knock on the
individual arts and writers, many of whom have taken the publisher's existing franchises in a number of interesting and often times thought provoking directions — it's just that Marvel is a big
company (one now owned by a giant corporation), and as such,
risk taking is likely not atop its list of priorities.
So when publishers give an advance to someone without their own audience, the publisher finds itself in a very high -
risk, venture - capital type model, but they are venture capitalists for
individuals rather than
companies.
The downside is that an
individual stock exposes you to financial
risk and is vulnerable to the effects of negative events at several levels: a stock is sensitive not only to shifts in the market but also to shifts in the underlying industry and
company it represents.
Underwriter: The insurance
company's employee trained to evaluate an
individual's
risk and determining premium rates.
What it does protect against is «unsystematic»
risk, which is specific to
individual companies or industries.
Individuals with ratings falling within this range are considered as
risks for the lending
company and maybe denied for credit applications.
It's understandable that investors are hesitant to pick
individual high yield bond issues and invest given solvency
risk of any one particular
company in conjunction with the hassle and minimum investment requirements many of them entail.
The
company said last week that fewer than 400,000 U.K.
individuals may have had their information put at
risk.
Q: Why do you suppose so few people in
risk management, and senior management at major financial firms, were unwilling to consider alternative views of the sustainability of the
risks being taken as the
risks got larger and larger relative to the equity of
individual companies, the industry as a whole, and the economy as a whole?
Each life insurance
company uses different algorithms to determine premiums based an
individual's health
risks, age and other factors.
Default
risk is the chance that
companies or
individuals will be unable to make the required payments on their debt obligations.